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Background: Spinal motoneuron neuroprotection by vitaminB12 was previously reported; the present study was
carried out to evaluate neuroprotectivity in the dorsal root ganglion sensory neuron.
Methods: In present study thirty-six Wister-Albino rats (aged 8–9 weeks and weighing 200–250 g) were tested. The
animals were randomly divided into 6 groups which every group contained 6 rats. Group A: received normal saline
(for 42 days); Group B: vitamin B12 was administered (0.5 mg/kg/day for 21 days); Group C: received vitamin B12
(1 mg/kg/day for 21days); Group D: received vitamin B12 (0.5 mg/kg/day for 42 days); Group E; received vitamin
B12 (1 mg/kg/day for 42 days); Group F; received no treatment. The L5 Dorsal Root Ganglion (DRG) neurons
count compared to the number of left and right neurons .Furthermore, DRG sensory neurons for regeneration
were evaluated 21 or 42 days after injury (each group was analyzed by One-Way ANOVA test).
Results: (1): The comparison of left crushed neurons (LCN) number with right non-crushed neurons in all
experimental groups (B, C, D and C), indicating a significant decline in their neurons enumeration (p<0/05). (2):
The comparison of test group’s LCN with the control group’s LCN revealed a significant rise in the number of
experimental group neurons (p<0/05). (3): Moreover, comparing the number of right neurons in experimental
groups with the number of neurons in crushed neurons indicated that the average number of right neurons
showed a significant increase in experimental groups (p<0/05).
Conclusion: Consequently, the probability of nerve regeneration will be increased by the increment of the
administered drug dosage and duration. On the other hand, the regeneration and healing in Dorsal Spinal
Ganglion will be improved by increase of administration time and vitamin B12 dose, indicating that such vitamin
was able to progress recovery process of peripheral nerves damage in experimental rats. Finally, our results have
important implications for elucidating the mechanisms of nerve regeneration. Moreover, the results showed that
vitaminB12 had a proliferative effect on the dorsal root ganglion sensory neuron.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/7395141841009256
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Unlike the central nervous system (CNS), neurons the
peripheral nervous system (PNS) can regenerate by its
own after physical injury because of activation of the in-
trinsic growth capacity of neurons [1].
The sciatic nerve, innervating the hind paw of the rat, is
frequently used to study peripheral nerve regeneration.
After crush injury, the fibers distal to the lesion undergo
Wallerian degeneration: the axon and myelin degenerate
and are ingested by Schwann cells and invading macro-
phages. Schwann cells surrounding the distal fibers prolifer-
ate so that the endoneurial tubes surrounding the original
nerve fibers remain intact, providing the environment
through which the regenerating axons can grow [2,3].
Peripheral nerve injury results in a loss of sensory and
motor function and nerve repair often results in poor
functional recovery. This is, in part, due to dorsal root
ganglion (DRG) cell death, regeneration errors or failure
to regenerate [4-6].
The sciatic nerve, comprising a mixed population of
motor and sensory axons, is a commonly used model for
studying nerve regeneration and it regeneration is ac-
companied by a variety of changes in the DRG neurons
cell bodies and regeneration is associated with the ex-
pression of new genes and proteins [2,7].
The DRG consists of heterogeneous population of
neurons. During development neurons must receive
appropriate neurotrophic support to survive which is
achieved by establishing appropriate peripheral target
connections via their neuritis [8].
Injury to DRG neuron cellular body or central axon re-
sults in somatosensory defects that do not recover spon-
taneously. Lost DRG neurons are not replaced. Central
axon response to injury is weak [9-11], leading to slow
axonal regrowth [12], Moreover, the proximal and distal
axonal processes of sensory neurons exhibit different re-
generation rates: Dorsal root axons regenerate at a lower
rate as compared to distal axon regrowth into the lesioned
spinal or sciatic nerve [12-15]. The reasons for this discrep-
ancy are not clear. The sensory neurons extending into the
sciatic nerve are located in the L4–L6 dorsal root ganglion
(DRGs). After sciatic nerve injury (SNI), the damaged
neurons suffer important changes to switch the neuro-
transmitter state to a pro-regenerative state [16].
B-vitamins were reported to attenuate degenerating
processes in the nervous system and therefore have been
clinically administered in a combination of B1 (thiamine),
B6 (pyridoxine), and B12 (cobalamine;Cbl)[17]. Ganglion
count in rat after SNI Vitamin B12(vit B12) is a micronu-
trient that plays significant roles in numerous biological
processes. It acts as a coenzyme, which is required for
metabolism of folate and biosynthesis of nucleotide [18].
It helps maintaining normal functions of the brain. vit




and has also been described in animal models [19]. The
CNS and especially the spinal cord are severely damaged
by vit B12deficiency [20].
Vit B12 is transported in the blood bound to trans-
cobalamin (TC) and internalized into cells by its recep-
tor, (TC-R, also named CD320). In the cells, vit B12 is
transferred to the cytoplasm by the lysosomal membrane
vit B12 transporter (LMBRD1) and serves as cofactor for
methyl malonylCoA mutase (Mut) and methionine syn-
thase (MS) [21]. Futhermore, vit B12 deficiency leads to
methionine deficiency, which is required for the synthe-
sis of both phospholipids and myelin. In addition, vita-
min B12 has been shown to exert antioxidant properties
[22], which result from direct and indirect effects [23].
In parallel of this research several studies regarding vit
B12 effects on nerves healing have been conducted.
Yagihashi et al. (1982) suggested that continuous treat-
ment with CH3-B12 had an ameliorative effect on the
peripheral nerve lesions in experimental diabetic neur-
opathy [24]. In addition, Okada et al. (2010) showed that
vit B12may provide a basis for more beneficial treatments
of nervous disorders through effective systemic or local
delivery of high doses of methylcobalamin to target or-
gans [25]. Watanabe in 1994 tested a high dosage of vit
B12 (500 mg/kg) on repairing the damaged nerves of
rats, somehow the potential return of muscles action
was significantly faster than that recorded in control
group, which treated with high dose of vitamin B12, rats
[26]. Swett et al. have studied on neurons dorsal root
ganglion count in rat after SNI [27].
In the present study, we investigated the neuroprotective
effects of vit B12on dorsal spinal ganglion of rats after the
experimental sciatic nerve crush.
Methods
Animals
All experimental protocols were approved by the local ani-
mal care committee in accordance with Faculty of Urmia
Veterinary Medicine office regulations. In current study, 36
Wister-albino rats of both sexes, weighing 200–250 g, with
averagely 6 weeks old were selected. The animals were kept
two by two in individual propylene cages under standard
laboratory conditions by the dimensions of 30×50×25 cm3.
Rats were maintained on a 12 hour light/dark cycle at
22±1°C and 50±10% humidity. The animals were kept in
standard room conditions and fed with standard rat diet
and water ad libitum.
Experimental protocol
The rats were divided into six groups and randomly al-
lotted into one of six experimental groups each group
contained six animals. Control animals in group A
received normal saline (for 42 days) (n=6), and test
animals in group B received vit B12following surgery





(0.5 mg/kg/day for 21 days) (n=6); however, test animals of
group C received vit B12following surgery (1 mg/kg/day for
21 days) (n=6). Test animals in group D received vit B12fol-
lowing surgery (0.5 mg/kg/day for 42 days) (n=6), whereas
test animals in group E received vit B12following surgery
(1 mg/kg/day for 42 days) (n=6), and in F: Sham group
had no surgery and vit B12injection, and were euthanized
after 42 days (n=6) in order to necropsy examination. In
addition, the vit B12in experimental group was injected
intraperitoneally.
Surgical technique
DRG of the spinal cord segment L5 which mainly sciatic
nerve is originated from is located in L1 vertebral col-
umn of the rat. Therefore, to remove it, according to the
method of the mentioned article, spinal segment, dorsal
root and related ganglion were removed from L1 of the
vertebral column [28]. All of the operations were
performed under microscope by same surgeon. The left
lateral thigh was operated after shaving and preparing
the skin with 10% povidone iodine. The sciatic nerve
was exposed by opening the fascial plane between the
gluteal and femoral musculature via a longitudinal inci-
sion (2–3 cm). All surgical procedures were carried out
under ketamine hydrochloride (75 mg /kg) and Xylazine
hydrochloride (5 mg/kg) anesthetic solutions, the sciatic
nerve of such 30 rats was exposed at mid-thigh level and
either crushed for 5 minutes with a pair of hemostatic
forceps (9–10 mm size). Subsequently, the muscles and
skin were separately sutured by 4/0 catgut thread and
allowed to breathe room air. The surgery was followed by
the animals’ special care until recovery.
Sample collection and microscopic examination
In both group animals (the control and experimental),
the left sciatic nerve had been crushed before the treat-
ment was started and then sutured. The animals were
anaesthetized with IP injection of sodium thiopenthal
after 21 and 42 days. The left and right dorsal root
ganglia-L5 and sections from distal parts of the right
(non-operated) and left (operated) sciatic nerves were
collected, fixed, and prepared for light microscopic
examination. A 10 mm-long sample of the right sciatic
nerve segment was removed without any injury, fixed,
and prepared for histopathological examination. Tissue
fragments were fixed in 10% neutral buffered formalin
solution (for 72 hours), upon stability embedded in par-
affin, sectioned at 5 μm thickness and stained with
hematoxylin and eosin (H&E).
Method of calculating the number of neurons
To determine the total number of neurons in the spinal
dorsal root node, the researchers used series of cross-




examination of each neuronal population the sensory
neurons, one of every 5 or 10 sections, were counted and
the total cells were multiplied by 5 or 10, respectively to
give an estimate of total cell numbers and neurons,
containing clear nuclear or nucleus were counted. Finally,
the total number of neurons in the dorsal root node was
compared to that of different groups. The neuronal
counting method was explained by Clarke [29]. Briefly,
the left and right L5 DRG were removed and post-fixed
in 4% paraformaldehyde then 30% sucrose, both at 4°C
for 24 h. the ganglia were blocked in tissue freezing
medium and stored at −80°C. Each entire ganglion was
cut into serial 15-μm cryosections and 1 from 4 sections
mounted onto gelatin-coated glass slides and dried over-
night. Neuron counts were performed using light micros-
copy. By a camera (DP11 camera) mounted on top of the
microscope, images from the sections were prepared at
magnifications of ×100, ×400, and ×1000, normal and
clear neuronal nuclei or nucleus were counted. Neuron
loss was calculated by subtracting the number of neurons
in ipsilateral ganglion from that in their contralateral
controls. Loss was then expressed as a percentage of the
neuron count in the control ganglia.
Statistical analysis
The data were expressed as mean ± standard deviation
(S ), and analyzed by repeated measures of variance. In
order to comparing number of counted neurons between
different groups a one-way ANOVA test and to evaluate
time interventions and drug dosage, Duncan test were
used. Experimental results were considered to be sig-
nificantly different from control values with p-value
set at.05 (SPSS).
Results
The procedures for reconstructing the regenerated DRG
neuron populations were identical to those used in an
earlier study, describing the normal sciatic DRG neuron
populations in the rat [30].
The results of the present study indicated that there
was a significant decrease in the number of DRG neu-
rons in all groups with SNI compared to early stages of
injury of the sham and control groups.
Furthermore, the results of this study demonstrated
that compared to the number of neurons in left ganglions
of crushing sciatic nerve (LGCSN) with neurons in right
ganglions of non-crushing sciatic nerve (RGNCSN) in
all experimental groups (EGs) (0/5 and 1 mg/kg, 21 and
42 days) a significant decrease in the number of EGs neu-
rons was recorded (p<0/05). This decrease was 7015± 132
to 6336± 142 respectively (p<0/05) (Table 1).
Moreover, comparison the number of neurons in
LGCSN (of each EG) with neurons in same side of the
control group (CG) (p<0/05) revealed a significant increase
LE
Table 1 Indicates of the average number of neurons of left
crushing sciatic nerve of all groups (A) compared to the
right non-crushing sciatic nerve of the same groups (B)
Groups Mean ±SD A decrease in the number of
neurons of A group in relation to B and
their comparison with sham group
21-day (0.5 mg/kg) 7015± 132
21-day (1 mg/kg) 7002± 109
42-day (0.5 mg/kg) 6749± 124
42-day (1 mg/kg) 6336± 142
Sham 8815± 114
Values are means ± SD (n=5). p<0.05 comparison to sham group.
Table 3 Indicates of the average increase in the number
of neurons of right non-crushing sciatic nerve of the
experimental group (A) compared to the non-crushing
sciatic nerve of the control group (B)
Groups Mean ±SD An increase in the number
of neurons of A group in relation to B
21-day (0.5 mg/kg) 7023± 164
21-day (1 mg/kg) 7028± 163
42-day (0.5 mg/kg) 7447± 119
42-day (1 mg/kg) 7095± 171
Values are means ± SD (n=4). p<0.05 comparison to the non-crushing sciatic
nerve of the control group.
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in the frequency of EG neurons (p<0/05). The increase was
7079± 102 to7779± 123 respectively (p<0/05) (Table 2).
On the other hand, comparison the number of right
neurons in EGs with the number of neurons in CG in-
dicated a significant increase in the average number of
right EGs neurons (p<0/05). This increase was 7023±
164 to 7095± 171 respectively (p<0/05) (Table 3).
In the treatment groups (0.5 mg/kg, 21 days) the num-
ber of DRG neurons after SNI revealed a significant rise
in the number of neurons compared to that of the CG
(p<0.05). Also the same significant difference was avail-
able in the number of neurons in other treatment groups
(1 mg/kg, 21 days) (p<0.05). The comparison between
two experimental 21-day groups of 0.5 mg/kg and 1 mg/kg
showed no significant difference.
Additionally, in the treatment group (1 mg/kg, 42 days),
the numbers of neurons solely demonstrated significant
rise in comparison with CG (p<0.05). The number of neu-
rons between 42-day group (0.5 mg/kg) and CG did not
show remarkable increase. In addition, there was not any
significant difference in 0.5 and 1 mg/kg 42-day groups
(Figure 1).
In order to investigate whether the neuroprotective effect
of vit B12 is dose-dependent, we administered one higher
dose of the vitamin (i.e., 1 mg/kg vit B12) 42 d after SNIRE
TRTable 2 Indicates of the average increase in the numberof neurons of left crushing sciatic nerve of experimental
group (A) compared to the right non-crushing sciatic
nerve of the control group (B)
Groups Mean ±SD An increase in the number of
neurons of A group in relation to B and
their comparison with control group
21-day (0.5 mg/kg) 7079± 102
21-day (1 mg/kg) 7069± 117
42-day (0.5 mg/kg) 7435± 200
42-day (1 mg/kg) 7779± 123
Control 7025± 173
Values are means ± SD (n=5). p=<0.05 comparison to the right non-crushing
sciatic nerve of the control group.D A
RT
ICsurgery. As shown in Figure 2B, higher doses of thevitamin alleviated the neuroprotective behavior moreeffectively than lower doses (compare to Figure 2A),
and stronger effects were again observed after the sec-
ond drug injection which was given 24 h after the first
injection. Thus, SNI-induced neuroprotective behavior
was dose-dependently inhibited by systemic administra-
tion of vitamins B12.
In order to examining the impact and simultaneous
interaction of both factors (time and treatment dosage)
in the number of neurons, a two-way ANOVA and
Duncan test were used. The comparison between the
control groups at 21 days after surgery represented a sig-
nificant difference with treatment groups both in 21 and
42 days treatment groups. On the other hand, the num-
ber of neurons in control groups at 42 days after surgery
was similar the number of neurons at 21-day groups for
both dosages. The results indicated that neuron injury
begins to repair 42 days after surgery while vit B12 accel-
erated such process conspicuously.
Discussion
Peripheral nerve regeneration is a complex biological
process involving interactions among multiple cells,
neurotrophic factors and extracellular matrice proteins
[31]. This report led us to believe that a systemic examin-
ation of DRG neuron responses to vit B12 is advantageous
to better understand the role of vitamin B12 in peripheral
nerve regeneration.
The present study evaluated the protective effects of
vit B12on the number of DRG cells recovery after indu-
cing SNI in the rats.
In a serious trauma like SNI, a short period of localized
ischemia is followed by evident increase in the pressure of
endoneural fluid and defect of the normal capillary blood
flow in the endoneurium [32]. Subsequently, Wallerian de-
generation may arise distal to the lesion [14,17]. It has been
shown that sciatic nerve crush leads to histological changes
in the DRG cells number [33]. Loss of the neurons occurs
and the nerve cells become less after peripheral nerve in-
jury in the DRG [15,18]. This finding is in accordance with
IC
LE
Figure 1 Histopathological evaluation of dorsal Root Ganglion neurons in the treatment and control groups. A: Death of dorsal Root Ganglion
(DRG) neurons in the control group that treated with normal saline, there were not nucleolus and nuclei (arrow), (H&G, x400). B: Note that of dorsal Root
Ganglion (DRG) neurons in the experimental groups that treated vitamins B12, there were nucleolus and nuclei (arrow), (H&Gx400).
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our results in which we showed the number of the cells
were decreased.
Histological changes, such as decrease in the number
of DRG cells after SNI, have been reported by other re-
searchers [34-36]. Our results are in accordance with
these findings, in which we demonstrated that the total
number of L5-DRG cells after SNI were decreased.
Vit B12is also a good scavenger of the reactive oxygen
species and is suggested to be a good neuroprotectant.
It can pass through the blood brain barrier, which is
an evidence of amplification of its neuroprotectant poten-
tial in neurodegenerative disorders such as Parkinson's and




Figure 2 Investigation neuron increase and decrease percentage in e
crushing sciatic nerve and control group.D A
RT
that vit B12 has protective effects after spinal cord injuries.
The previous studies have stressed the anti-apoptotic and
anti-necrotic effects of the vit B12 on the neurons [38].
These reports may explain the beneficial effects of vit B12
in the present study after SNI. These properties including
anti-inflammatory, antioxidant, anti-apoptotic and anti-
necrotic might be effective in the present study.
In previous reports on the effects of vit B12 on neurons
in vivo, high levels of vit B12 improved nerve conduction
and regeneration in streptozotocin-diabetic rats [17], and
experimental acrylamide neuropathy [26]. We used a
rat SNI model in the present study to evaluate the ef-
fects of vit B12 in vivo. However, we used continuousxperiment groups compared to the right ganglions of non-





administration of doses of vit B12 (0.5 and 1 mg/kg/day)
higher than that used in previous reports (500 μg/kg/day).
Our morphological and histological evaluation offers a pos-
sible explanation of this phenomenon. Vit B12increased the
regeneration of axons.
We consider that repair discrepancy is due to the dif-
ferences in the doses of vit B12and time of administra-
tion. In our study, vit B12had not remarkable affect on
neurons at low-dose concentrations, especially with low-
dose administration or short time, because the concen-
tration of vit B12declines immediately [39] and the
absorption of vit B12from the ileum and entire intestine
is regulated by limitation of binding to gastric intrinsic
factor and passive diffusion [40,41]. From the results of
our study, we consider that it is necessary to devise new
clinical methods, such as high-dose systemic or long
time, to deliver high doses of vit B12 to target organs to
treat nervous disorders more effectively. Thus, the high-
dose vit B12 treatment together with long time might
have the potential to treat not only peripheral nerve in-
jury but also central nervous injury.
The results of our study indicated that the experimen-
tal groups, under treatment with vit B12, were prevented
from reducing the number of neurons in DRG (Table. 2).
Moreover, the DRG neurons decrease of left side of the
operated experimental group compared to non-operated
right side of the same group was slightly, especially it
reached to the lowest degree (6336± 142) in 1mg/kg
dosage in 42-day, and the result was significant com-
pared to the other groups (p<0/05). On the other hand,
the left neurons of 0/5mg/kg group in 21-day shows an
increase of 7779± 123 compared to the same ganglion of
the control group.
Also, according to Table 3, the neuronal mean increase
shows a significant rise in association with the increase
of vit B12 dosage and time that such variation in 0/5
and1 mg/kg group reached to 7023± 164 to 7095±
171respectively (Table 3). In addition, the decrease in
the neurons death percentage of the right side of the
non-crushing sciatic nerves compared to the same side
of the control group was 20/32, 20/27, 20/05 and 19/51
percent (Table 3 and Figure 1 ).
On the other hand, the regeneration and healing in
Dorsal Spinal Ganglion will be improved by increase of
administration time and vit B12 dose, indicating that
such vitamin was able to progress recovery process of
peripheral nerves damage in experimental rats.
In parallel with our research several studies have been
conducted. Yamatsu evaluated the effect of vitaminB12
on the nerve repair after a crush injury. Vit B12 demon-
strated significant increase in the regeneration and im-
provement on SNI tests suggesting an inhibitory effect
on the nerve degeneration and facilitating the regene-




effectiveness of vit B12 on nerve regeneration and found
that it demonstrated the greatest improvement on nerve
regeneration [25]. Yamazaki also demonstrated that vit
B12 improves the neuromuscular junction by decreasing
nerve degeneration and improving nerve regeneration in
the motor nerve terminals in a gracile axonal dystrophy
mice model [43].
In addition to, the results of this study confirm the
results of one-way ANOVA and represent that the neu-
rons construction and repairing started by time passage.
Because the average number of neurons in under-
prescription groups by vit B12 in 0.5mg/Kg and 1mg/Kg
doses increased in 42-day experimental groups from
7435± 200 to7779± 123, and this difference was obvious
and significant between the control group and 42-day ex-
perimental group in 1mg/kg dosage (p<0/05). In agreement
with our study, Yagihushi et al., 1976 suggested that a
constant 16-week cures by vit B12 (500 microgram/kg)
had a completely repairing effect on the injured periph-
eral nerves in experimental diabetic neuropathy of rats.
In another study, Taniguchi et al., 1987 indicated that vit
B12 cured neuropathy in uromicina patients. They ad-
vised that vitamin B12 could be used as a cure in such
forms of neuropathy [44]. In addition, another study by,
Hasegawa et al. (1978) studies showed that the vitamin B
complex facilitated functional recovery from nerve injury
faster than its components, and showed that B1 and B12
had significant facilitating effects on the functional re-
covery as well [45].
In this study, we showed that the vitamin B12 was the
most effective in promoting neuronal survival in DRG
neurons. These results suggest that the metabolic path-
way of vit B12, is associated with neuronal survival, but
further understanding of this role and development of
an effective delivery system for vitamin B12 may enable
us to treat several nervous disorders and to obtain new
insights into nerve regeneration.
Conclusion
Our study suggests that vitamin B12 has neuroprotective
and restorative effects on secondary pathochemical events
after sciatic nerve injury in rats. These restorative effects
have been mainly observed on neuronal numbers. We be-
lieve that further preclinical research into the utility of Cbl
may indicate its usefulness as a potential treatment on
neurodegeneration after trauma in rats but more and de-
tailed experimental studies are needed to determine the ef-
fects of Cbl on the detrimental results of secondary sciatic
nerve injury in human and animal. Furthermore, this study
revealed that the regeneration and healing in Dorsal Spinal
Ganglion will be improved by increase of administration
time and vitamin B12 dose, indicating that such vitamin
was able to progress recovery process of peripheral nerves
damage in experimental rats.
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